FdaApplication
BLA 103234
Identifiers
- fda_app_no: BLA103234
Properties
| Property | Value |
|---|---|
| applicant_name | Amgen Inc. |
| application_type | BLA |
| approval_date | 1989-06-01 |
Products (7)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EPOGEN/PROCRIT | EPOETIN ALFA | 20,000UNITS/ML | VIAL;MULTIDOSE |
| EPOGEN/PROCRIT | EPOETIN ALFA | 10,000UNITS/ML | VIAL;SINGLE-USE |
| EPOGEN/PROCRIT | EPOETIN ALFA | 4,000UNITS/ML | VIAL;SINGLE-USE |
| EPOGEN/PROCRIT | EPOETIN ALFA | 3,000UNITS/ML | VIAL;SINGLE-USE |
| EPOGEN/PROCRIT | EPOETIN ALFA | 2,000UNITS/ML | VIAL;SINGLE-USE |
| PROCRIT | EPOETIN ALFA | 40,000UNITS/ML | VIAL;SINGLE-USE |
| EPOGEN/PROCRIT | EPOETIN ALFA | 20,000UNITS/2ML (10,000UNITS/ML) | VIAL;MULTIDOSE |
7 products